Pharmacological therapy is relatively cost-effective when added to smoking cessation counselling: Commentary

Evidence-Based Healthcare

Volumn 7, Issue 1, 2003, Pages 44-46

  Munafó, Marcus ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COUNSELING; DATA BASE; DECISION MAKING; ECONOMIC ASPECT; EVALUATION; HEALTH SURVEY; HUMAN; NICOTINE REPLACEMENT THERAPY; NOTE; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 23044497155     PISSN: 14629410     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1462-9410(02)00142-0     Document Type: Note

References (9)

1. Munafó MR, Drury M, Wakely G, Chambers R. Smoking cessation in primary care. Oxford: Radcliffe Medical Press, 2002.
2. Silagy C, Lancaster T, Stead L et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue I. Oxford: Update Software, 2002.
3. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue I. Oxford: Update Software, 2002.
4. McEwen A, West R. Smoking cessation activities by general practitioners and practice nurses. Tob Control 2000; 10: 232-270.
5. Velicer WF, Prochaska JO, Bellis JM et al. An expert system intervention for smoking cessation. Addict Behav 1993; 18: 269-290.
6. Lichtenstein E, Glasgow RE. Smoking cessation: what have we learned over the past decade? J Consulting Clin Psychol 2002; 60: 518-527.
7. Velicer WF, Prochaska JO, Fava JL et al. Interactive versus noninteractive interventions and dose-response relationships for stage-matched smoking cessation programs in a managed care setting. Health Psychol. 1999; 18: 21-28.
8. Lennox AS, Osman LM, Reiter E et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. BMJ 2001; 322: 1396.
9. Walton R, Johnstone E, Munafó MR et al. Molecular basis of tobacco addiction and progress towards personalised therapy. Trends Mol Med 2001; 7: 70-76.